Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07532031) titled 'APT-weighted and Diffusion MRI for Characterizing Tumor Infiltration in High-Grade Gliomas' on April 8.

Study Type: Observational

Primary Sponsor: IRCCS Ospedale San Raffaele

Condition: High-Grade Glioma Glioblastoma Brain Tumor Adult

Intervention: Diagnostic Test: Standard-of-care MRI data, including APT and diffusion imaging, will be analyzed to generate quantitative maps of tumor infiltration within the peri-tumoral region.

Recruitment Status: Not recruiting

Date of First Enrollment: April 1, 2026

Target Sample Size: 20

To know more, visit https://clinicaltrials.gov/study/NCT07532031

Disclaimer: Curat...